Literature DB >> 7823064

Brain magnetic resonance imaging and multimodal evoked potentials in benign and secondary progressive multiple sclerosis.

M Filippi1, A Campi, S Mammi, V Martinelli, T Locatelli, G Scotti, S Amadio, N Canal, G Comi.   

Abstract

Brain MRI and multimodal evoked potentials (EPs) were obtained for 13 patients with benign multiple sclerosis and 13 patients with secondary progressive multiple sclerosis, matched for age and duration of the disease, to investigate the nature of the disability in multiple sclerosis. Patients with secondary progressive multiple sclerosis had significantly greater lesion loads for five of seven periventricular regions and for three of nine regions separate from the ventricles. Patients with secondary progressive multiple sclerosis also had more severe infratentorial atrophy scores (p = 0.04), whereas there were no differences between the two groups in number and extent of enhancing lesions. The frequencies were significantly higher and severities greater for multimodal EP abnormalities of all the modalities in patients with secondary progressive multiple sclerosis. At least one EP component was absent in 12 (92%) patients with secondary progressive multiple sclerosis but in only one patient (8%) with benign multiple sclerosis (p < 0.001). There was neurophysiological evidence for cervical cord involvement in eight (61%) patients with secondary progressive multiple sclerosis and in one with benign multiple sclerosis (p < 0.01). These data indicate that the total amount of lesions, the distribution, and the nature of the pathological process might all account for the development of disability in multiple sclerosis.

Entities:  

Mesh:

Year:  1995        PMID: 7823064      PMCID: PMC1073265          DOI: 10.1136/jnnp.58.1.31

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  34 in total

Review 1.  The pathological evolution of multiple sclerosis.

Authors:  W I McDonald; D H Miller; D Barnes
Journal:  Neuropathol Appl Neurobiol       Date:  1992-08       Impact factor: 8.090

2.  Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications.

Authors:  A G Kermode; A J Thompson; P Tofts; D G MacManus; B E Kendall; D P Kingsley; I F Moseley; P Rudge; W I McDonald
Journal:  Brain       Date:  1990-10       Impact factor: 13.501

3.  The longstanding MS lesion. A quantitative MRI and electron microscopic study.

Authors:  D Barnes; P M Munro; B D Youl; J W Prineas; W I McDonald
Journal:  Brain       Date:  1991-06       Impact factor: 13.501

4.  Quantitative MR in the diagnosis of multiple sclerosis.

Authors:  V M Haughton; F Z Yetkin; S M Rao; A A Rimm; M E Fischer; R A Papke; R K Breger; B O Khatri
Journal:  Magn Reson Med       Date:  1992-07       Impact factor: 4.668

5.  Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration.

Authors:  A J Thompson; D Miller; B Youl; D MacManus; S Moore; D Kingsley; B Kendall; A Feinstein; W I McDonald
Journal:  Neurology       Date:  1992-01       Impact factor: 9.910

6.  Quantitative multiple sclerosis plaque assessment with magnetic resonance imaging. Its correlation with clinical parameters, evoked potentials, and intra-blood-brain barrier IgG synthesis.

Authors:  R W Baumhefner; W W Tourtellotte; K Syndulko; V Waluch; G W Ellison; L W Meyers; S N Cohen; M Osborne; P Shapshak
Journal:  Arch Neurol       Date:  1990-01

7.  Multiple sclerosis: magnetic resonance imaging, evoked responses, and spinal fluid electrophoresis.

Authors:  M R Farlow; O N Markand; M K Edwards; J C Stevens; O J Kolar
Journal:  Neurology       Date:  1986-06       Impact factor: 9.910

8.  Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging.

Authors:  V Dousset; R I Grossman; K N Ramer; M D Schnall; L H Young; F Gonzalez-Scarano; E Lavi; J A Cohen
Journal:  Radiology       Date:  1992-02       Impact factor: 11.105

9.  Improved correlation of magnetic resonance imaging (MRI) with clinical status in multiple sclerosis (MS) by use of an extensive standardized imaging-protocol.

Authors:  L Truyen; J Gheuens; F L Van de Vyver; P M Parizel; G V Peersman; J J Martin
Journal:  J Neurol Sci       Date:  1990-05       Impact factor: 3.181

10.  Major differences in the dynamics of primary and secondary progressive multiple sclerosis.

Authors:  A J Thompson; A G Kermode; D Wicks; D G MacManus; B E Kendall; D P Kingsley; W I McDonald
Journal:  Ann Neurol       Date:  1991-01       Impact factor: 10.422

View more
  8 in total

1.  Quantitative functional MR imaging of the visual cortex at 1.5 T as a function of luminance contrast in healthy volunteers and patients with multiple sclerosis.

Authors:  Scott H Faro; Feroze B Mohamed; Joseph I Tracy; Robert M Elfont; Alexander B Pinus; Fred D Lublin; Robert A Koenigsberg; Cheng Y Chen; Fong Y Tsai
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

Review 2.  Magnetic resonance in monitoring the natural history of multiple sclerosis and the effects of treatment.

Authors:  M Filippi; M Rovaris; G Comi
Journal:  Ital J Neurol Sci       Date:  1996-12

3.  Multimodal evoked potentials to assess the evolution of multiple sclerosis: a longitudinal study.

Authors:  L Leocani; M Rovaris; F M Boneschi; S Medaglini; P Rossi; V Martinelli; S Amadio; G Comi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05-30       Impact factor: 10.154

4.  A spinal cord MRI study of benign and secondary progressive multiple sclerosis.

Authors:  M Filippi; A Campi; B Colombo; C Pereira; V Martinelli; C Baratti; G Comi
Journal:  J Neurol       Date:  1996-07       Impact factor: 4.849

5.  Role of B:T cell ratio in suppression of clinical signs: a model for silent MS.

Authors:  Lisa K Peterson; Ikuo Tsunoda; Jane E Libbey; Robert S Fujinami
Journal:  Exp Mol Pathol       Date:  2008-04-08       Impact factor: 3.362

6.  Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis.

Authors:  M Filippi; A Campi; V Martinelli; B Colombo; T Yousry; N Canal; G Scotti; G Comi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-11       Impact factor: 10.154

Review 7.  Nuclear magnetic resonance monitoring of treatment and prediction of outcome in multiple sclerosis.

Authors:  D H Miller; A J Thompson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

8.  Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis.

Authors:  Xavier Giffroy; Nathalie Maes; Adelin Albert; Pierre Maquet; Jean-Michel Crielaard; Dominique Dive
Journal:  BMC Neurol       Date:  2016-06-01       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.